Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.
Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs work -- and are they safe -- in pregnant and breastfeeding women?
Three researchers talk about ongoing HIV cure research within the AIDS Clinical Trials Group, treatment interruptions, and when we might see a cure.
The noted HIV researcher reflects on recent advances, the search for a cure, and the long road ahead.
Sanjabi talks about her early interest in science, her innovative research toward an HIV cure, and the importance of mentoring early career investigators.
Paul Sax, M.D., discusses the clinical importance of new drugs in development highlighted at CROI 2017 -- and about what else is on the near horizon when it comes to antiretroviral therapies for HIV.
Clinical trials (the study of new treatments in people) are critical if we are ever to find better ways to treat HIV, and, eventually, a cure. Unfortunately, people of color, women, and IV drug users have been under-represented in these trials for ma...
The historical record of progress in AIDS research lies not only in the medical literature, but also in the community-produced clinical trial directories that have tracked experimental protocols as they opened and closed over the years. Studies of fa...
The U.S. government's premier clinical trials group for studying HIV therapies is adrift. The HIV Research Agenda Committee (HIV RAC) of the Adult AIDS Clinical Trials Group (AACTG) sees its mission as performing small, scientifically challenging stu...